18.08
-0.12
(-0.68%)
At close: January 28 at 5:24:59 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Lennart Hansson Ph.D. | Co-founder & Chairman of the Board | 494k | -- | 1956 |
| Mr. Christer Ahlberg | CEO & President | 4.84M | -- | 1971 |
| Mr. Peter Unge | Co-founder & Director | 2.28M | -- | 1951 |
| Mr. Kjell Andersson | Co-Founder & Chief Scientific Officer | -- | -- | 1957 |
| Ms. Maria Engstrom | Chief Financial Officer | -- | -- | 1972 |
| Mr. Gosta Hiller | Chief Operating Officer | -- | -- | 1968 |
| Mr. Bengt Erlandsson | Head of CMC & IP | -- | -- | 1966 |
| Ms. Kajsa Larsson | Chief Medical Officer | -- | -- | 1966 |
| Ms. Malin Filler | Head of Regulatory Affairs | -- | -- | 1968 |
Cinclus Pharma Holding AB (publ)
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 12
Description
Cinclus Pharma Holding AB (publ), a clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases. Its lead product is linaprazan glurate for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer bacteria Helicobacter pylori (H. pylori). The company was founded in 2014 and is based in Stockholm, Sweden.
Corporate Governance
Cinclus Pharma Holding AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available